Buscar
Mostrando ítems 11-20 de 183
Incidence of psychiatric side e¡ects during pegylated interferon- a retreatment in nonresponder hepatitisCvirus-infected patients
(2007)
Objective: Evaluate the incidence of mental disorders using pegylated interferon plus ribavirin retreatment in nonresponder hepatitis C virus-infected patients.
Method: The Mini-International Neuropsychiatric Interview ...
Influence of HLA alleles in response to treatment with pegylated interferon-alpha and ribavirin in patients with chronic hepatitis C
(Wiley-Blackwell, 2012-08-01)
The objective of this study was to analyse the possible role of HLA polymorphism of chronically infected hepatitis C virus patients in the response outcome to treatment with pegylated interferon-alpha plus ribavirin. To ...
Influence of HLA alleles in response to treatment with pegylated interferon-alpha and ribavirin in patients with chronic hepatitis C
(Wiley-Blackwell, 2012-08-01)
The objective of this study was to analyse the possible role of HLA polymorphism of chronically infected hepatitis C virus patients in the response outcome to treatment with pegylated interferon-alpha plus ribavirin. To ...
Pharmacodynamics of PEG-IFN-alpha-2a and HCV Response as a Function of IL28B Polymorphism in HIV/HCV-Coinfected Patients
(LIPPINCOTT WILLIAMS & WILKINS, 2011)
We examined the association between IL28B single-nucleotide polymorphism rs12979860, hepatitis C virus (HCV) kinetic, and pegylated interferon alpha-2a pharmacodynamic parameters in HIV/HCV-coinfected patients from South ...
IL28B polymorphisms associated with therapy response in Chilean chronic hepatitis C patients
(2011)
AIM: To analyze the association of three IL28B single nucleotide polymorphisms with response to therapy in Chilean patients infected with hepatitis C virus (HCV)). METHODS: We studied two groups of patients with chronic ...
Host-genetic combination based on IFNL3/IFNL4 polymorphism with other prognostic variables increases sustained response in antiviral therapy with pegylated interferon alpha
(Fiocruz/Instituto de Tecnologia em Imunobiológicos, 2019)
Therapeutic effectiveness of biosimilar standard interferon versus pegylated interferon for chronic hepatitis C genotypes 2 or 3
(Brazilian Society of Infectious Diseases, 2012)
Alternativas de tratamento para hepatite viral crônica B: análise de custo-efetividade
(Universidade Federal de Minas GeraisUFMG, 2011-02-17)
Introduction: Hepatitis B is one of the most common infectious diseases worldwide and has been showing increasing expenditures in the Brazilian Unified Healh System (SUS). Objectives: To perform a pharmacoeconomic and ...